A phase 1 feasibility trial of BE-CAR33, an "off-the-shelf" base-edited CAR33 T cell therapy for acute myeloid leukemia.

Georgiadis C, Chiesa R, Rashed H, Hughes BK, Preece R, Gough O, Pinner D, Adams S, Thomas R, Etuk A, Mishra A, Zhan H, Braybrook T, Gilmour K, Potter V, Bartram J, Ancliff P, Sauer M, Qasim W, Base Edited-CAR T cell group, Base-Edited CAR T Group.

Open source

DOI: 10.1126/scitranslmed.aei0875
Published: 2026-08-19
Container: Sci Transl Med
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1126/scitranslmed.aei0875,
  title = {A phase 1 feasibility trial of BE-CAR33, an "off-the-shelf" base-edited CAR33 T cell therapy for acute myeloid leukemia.},
  author = {Georgiadis C and  Chiesa R and  Rashed H and  Hughes BK and  Preece R and  Gough O and  Pinner D and  Adams S and  Thomas R and  Etuk A and  Mishra A and  Zhan H and  Braybrook T and  Gilmour K and  Potter V and  Bartram J and  Ancliff P and  Sauer M and  Qasim W and  Base Edited-CAR T cell group and  Base-Edited CAR T Group.},
  year = {2026},
  journal = {Sci Transl Med},
  doi = {10.1126/scitranslmed.aei0875},
  url = {https://doi.org/10.1126/scitranslmed.aei0875}
}

RIS

TY  - JOUR
TI  - A phase 1 feasibility trial of BE-CAR33, an "off-the-shelf" base-edited CAR33 T cell therapy for acute myeloid leukemia.
AU  - Georgiadis C
AU  -  Chiesa R
AU  -  Rashed H
AU  -  Hughes BK
AU  -  Preece R
AU  -  Gough O
AU  -  Pinner D
AU  -  Adams S
AU  -  Thomas R
AU  -  Etuk A
AU  -  Mishra A
AU  -  Zhan H
AU  -  Braybrook T
AU  -  Gilmour K
AU  -  Potter V
AU  -  Bartram J
AU  -  Ancliff P
AU  -  Sauer M
AU  -  Qasim W
AU  -  Base Edited-CAR T cell group
AU  -  Base-Edited CAR T Group.
PY  - 2026
JO  - Sci Transl Med
DO  - 10.1126/scitranslmed.aei0875
UR  - https://doi.org/10.1126/scitranslmed.aei0875
ER  -

APA

C, G., R, C., H, R., BK, H., R, P., O, G., D, P., S, A., R, T., A, E., A, M., H, Z., T, B., K, G., V, P., J, B., P, A., M, S., W, Q., group, B. E. T. C., & Group., B. C. T. (2026). A phase 1 feasibility trial of BE-CAR33, an "off-the-shelf" base-edited CAR33 T cell therapy for acute myeloid leukemia.. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aei0875

Source records

europe-pmc · retrieved 2026-09-25T13:11:50.190Z